No Detail Found!

Effect of Atherosclerosis Developed from Diabetes on Ceruloplasmin Concentration, Ceruloplasmin Ferroxidase Activity and its Specific in Sera of Diabetic Iraqi Patients with Atherosclerosis

Author(s)
SAFA NAJI JASIM Department of chemistry, College of science, University of Baghdad Iraq
JWAN ABDULMOHSIN ZAINULABDEEN Department of chemistry, College of science, University of Baghdad Iraq
Abstract
Atherosclerosis is one of the common complications in patients with advanced type 2 diabetes (T2DM). This study aims to  detect the influence of this complication on ceruloplasmin concentration, ceruloplasmin ferroxidase activity and its specific  activity. Samples were collected in the morning from males and females’ individuals (50-69years) who attended Ibn Al-Bitar  center for cardiac surgery. Fasting serum glucose (F.S.G), malondialdehyde (MDA), Ceruloplasmin concentration,  Ceruloplasmin ferroxidase activity and its specific activity were all measured after the participants fasted for about 8 12hours.The F.S.G, Ceruloplasmin Ferroxidase activity and its specific activity had a high significant increase at p<0.001.  Meanwhile and Ceruloplasmin concentration had a significant increase at p<0.05. 
Publication Details
Page(s) 607-609
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 06, Year: 2022

Request the full text from PASTIC

Keywords
Diabetes, Diabetes, Diabetes, atherosclerosis, Diabetes, Diabetes, Ceruloplasmin, Ceruloplasmin, Ferroxidase
References
Galicia-Garcia U.,Benito-Vicente A.,Jebari S.,Larrea-Sebal A.,Siddiqi H.,Uribe K. B.,Ostolaza H.,C. H. .2020 .Pathophysiology of type 2 diabetes mellitus. International journal of molecular sciences, 21(17) : 6275.
Sudesna C.,Khunti K.,Davies M. J. .2017 .. Type 2 diabetes. The Lancet, 389(10085) : 2239-2251.
AlSaraj F. .2015 .Pathogenesis of type 2 diabetes mellitus. In Treatment of Type 2 Diabetes, : .
Roden M.,Shulman G. I. . .The integrative biology of type 2 diabetes.. , : .
.2019 .. Nature, 576(7785) : 51-60.
B. .2018 .Type 2 diabetes. The Lancet, 391(10127) : 1261.
Ma Q.,Li Y.,Wang M.,Tang Z.,Wang T.,Wang C.,Zhao C.,B. C. .1834 .Progress in metabonomics of type 2 diabetes mellitus. Molecules, 23(7) : .
Wu Y.,Ding Y.,Tanaka Y.,W. Y. . .Risk factors contributing to type 2 diabetes and recent advances in the treatment and prevention. , : .
.2014 .. International journal of medical sciences, 11(11) : 1185.
Giacco F.,Brownlee M. .2010 .. Circ. Res, 107 : 1058-1070.
Astiarraga B.,Chueire V. B.,Souza A. L.,Pereira-Moreira R.,Natali S.,Tura A.,Mari A.,Ferrannini A.,Muscelli E.,E. E. . .Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes.. , : .
.2018 .. Diabetologia, 61(8) : 1829-1837.
Vona R.,Cittadini L.,Straface C.,Pietraforte E.,D. E. .2019 .Biomarkers of oxidative stress in metabolic syndrome and associated diseases. Oxidative medicine and cellular longevity, : .
Lopez M. J.,Royer A.,Shah N. J. .2021 .. , : .
Frieden E.,Hsieh H. S. .1976 .Ceruloplasmin: the copper transport protein with essential oxidase activity. Adv Enzymol Relat Areas Mol Biol, 44 : 187-236.
Menzel A.,Samouda H.,Dohet F.,Loap S.,M. S. S.,T. S. .2021 .Common and novel markers for measuring inflammation and oxidative stress ex vivo in research and clinical practice-Which to use regarding disease outcomes. Antioxidants, 10(3) : 414.
White C. A.,Kennedy J. F.,Carbohydrates J. F. . .. volume VI: Metabolites, 1 : .
Bergmeyer and M. GraRl .1985 .. 00;seriessubscriptionprice 130.00, DM 295.00. ISBN 3‐527‐26046‐3, (DM350) : .
Tietz N. W. .2006 .Tietz Clinical guide to laboratory tests. , : .
Draper H. H.,M. H. H. .1990 .Malondialdehyde determination as index of lipid Peroxidation. , 186 : 421-431.
Rice E. W. .1962 .Standardization of ceruloplasmin activity in terms of international enzyme units: Oxidative formation of “Bandrowski's base” from p-phenylenediamine by ceruloplasmin. Analytical biochemistry, 3(6) : 452-456.
.1951 .Coeruloplasmin as an enzyme. Aeta chem. scand. 5, (195t) : .
.1998 .. Clinical chemistry, 44(11) : 2313-2319.
Mandal M.,Varghese A.,Gaviraju V.,Talwar S. N.,Malini S. S. .2019 .Impact of hyperglycaemia on molecular markers of oxidative stress and antioxidants in type 2 diabetes mellitus. Clinical Diabetology, 8(4) : 215-222.
Sharma M.,Bhatia K.,Misra P.,Ambade S.,Mukherjee V. N.,B. V. N. . .A STUDY OF PLASMA GLUCOSE AND SERUM CERULOPLASMIN IN TYPE-2 DIABETES MELLITUS (T2DM) AT A TERTIARY CARE HOSPITAL. , : .
Sharma V. K.,Tumbapo A.,Pant V.,Aryal B.,Shrestha S.,Yadav B. K.,Tuladhar E. T.,Bhattarai A.,Raut M.,Ceruloplasmin M. . .. , 24 : .
.2018 .potential marker for glycemic status and its relationship with lipid profile in Type II diabetes mellitus. Asian Journal of Medical Sciences, 9(2) : 13-18.
Al-Hmmamy S.,Najaf AL,Governorate AL,Batra N.,H. S. N.,Gupta M.,Mahindra S.,V. S. .2013 .Evaluation of Serum Ceruloplasmin Levels as a Biomarker for Oxidative Stress in Patients With Diabetic Retinopathy. No. (7), : .
.2021 .. Cureus, 13(2) : .
Shukla N.,Maher J.,Masters J.,Jeremy G. D.,J. Y. G. D. .2006 .Does oxidative stress change ceruloplasmin from a protective to a vasculopathic factor?. Atherosclerosis, 187(2) : 238-250.
Arenas de Larriva A. P.,Limia-Pérez L.,Alcalá-Díaz J. F.,Alonso A.,López-Miranda J.,Delgado-Lista J. .2020 .. Ceruloplasmin and Coronary Heart Disease-A Systematic Review. Nutrients, 12(10) : 3219.
Voynova I. V.,Kostevich V. A.,Elizarova A. Y.,Karpenko M. N.,Sokolov A. V. . .The specific activity of proteins involved in iron metabolism depends on compensation of type 2 diabetes mellitus. , : .
.2019 .. Medical academic journal, 19(2) : 37-42.
Sacheat H.,Al-Mudhaffar S.,S. S. .2021 .In Evaluation of Ceruloplasmin ferroxidase activity and lipid profiles in patients with Valvular heart diseases. Journal of Physics: Conference Series, : 022066.
0

Citations

0

Downloads

74

Views